ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

New NCI advisory Boards Appointed, Begin Review Of NCI Programs

March 29, 1996

Research Policy: NIH Trials Don’t Enroll Enough Women to Allow Analysis, GAO Says in Report

May 12, 2000

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

In Brief: New Environmental Cancer Research Center Opened In Texas; Califano: No Promises

July 7, 1978

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997